» Articles » PMID: 32399737

IL-6, IL-8 and IL-10 Polymorphisms May Impact Predisposition of Alzheimer's Disease: a Meta-analysis

Overview
Publisher Springer
Specialty Neurology
Date 2020 May 14
PMID 32399737
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Gene polymorphisms in interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10) may affect the predisposition of Alzheimer's disease (AD), but the results of the so far published studies remain controversial. The authors conducted this meta-analysis to assess relationships between IL-6/IL-8/IL-10 polymorphisms and predisposition of AD by pooling the findings of so far published studies. A comprehensive search of Pubmed, Embase, Web of Science, and CNKI was endorsed by the authors to identify the already published studies. Forty-five studies were found to be eligible for meta-analyses. The pooled meta-analyses results showed that genotypic frequencies of IL-6 - 174 G/C, IL-6 - 572 G/C and IL-10 - 1082 A/G polymorphisms among patients with AD and controls differed significantly. Moreover, genotypic frequencies of IL-6 - 174 G/C, IL-6 - 572 G/C, and IL-8 - 251 A/T polymorphisms among patients with AD and controls in Asians also differed significantly. But no such genotypic frequencies' differences were observed for IL-10 - 819 C/T and 592 C/A polymorphisms. This meta-analysis suggests that IL-6 - 174 G/C, IL-6 - 572 G/C, and IL-10 - 1082 A/G polymorphisms may affect the predisposition of AD in overall population. Moreover, IL-6 - 174 G/C, IL-6 - 572 G/C, and IL-8 - 251 A/T polymorphisms may affect the predisposition of AD in Asians.

Citing Articles

Endoplasmic Reticulum Stress Differently Modulates the Release of IL-6 and IL-8 Cytokines in Human Glial Cells.

Sokolowska P, Wiktorowska-Owczarek A, Tambor J, Gawlak-Socka S, Kowalczyk E, Jozwiak-Bebenista M Int J Mol Sci. 2024; 25(16).

PMID: 39201378 PMC: 11354802. DOI: 10.3390/ijms25168687.


IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions.

Shkundin A, Halaris A J Pers Med. 2024; 14(5).

PMID: 38793070 PMC: 11122344. DOI: 10.3390/jpm14050488.


Brain metabolism in Alzheimer's disease: biological mechanisms of exercise.

Xu L, Liu R, Qin Y, Wang T Transl Neurodegener. 2023; 12(1):33.

PMID: 37365651 PMC: 10294518. DOI: 10.1186/s40035-023-00364-y.


Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer's Disease and Dementia.

Vogrinc D, Gregoric Kramberger M, Emersic A, cucnik S, Goricar K, Dolzan V Antioxidants (Basel). 2023; 12(2).

PMID: 36829875 PMC: 9952323. DOI: 10.3390/antiox12020316.


Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease.

Gu X, Lai D, Liu S, Chen K, Zhang P, Chen B Front Aging Neurosci. 2022; 14:949083.

PMID: 35875800 PMC: 9300955. DOI: 10.3389/fnagi.2022.949083.


References
1.
Ramanan V, Saykin A . Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis. 2013; 2(3):145-75. PMC: 3783830. View